Cargando…

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?

Detalles Bibliográficos
Autor principal:	Davari, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876564/ https://www.ncbi.nlm.nih.gov/pubmed/25317179

Ejemplares similares

On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
por: Carta, Andrea, et al.
Publicado: (2020)

Drug Policy Research & Pharmacoeconomics
Publicado: (2008)

Cough up for just a cup of coffee: Pharmacoeconomics of depression
por: Swaminath, G.
Publicado: (2008)

The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers
por: Proudman, David, et al.
Publicado: (2021)

Engaging with Policy Makers: The Need for Accessible and Timely Health Services and Systems Research in 2020
por: Sutherland, Jason M.
Publicado: (2020)

It's Only a Pharmacoeconomic Model--Believe It or Not
por: Fairman, Kathleen A., et al.
Publicado: (2008)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Systematic Reviews: Perhaps “The Answer to Policy Makers’ Prayers”?
por: Fox, Daniel M., et al.
Publicado: (2014)

Incremental Cost-effectiveness Thresholds for Policy Decision-makers
por: Al-Zakwani, Ibrahim
Publicado: (2022)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Zero to maker: learn (just enough) to make (just about) anything
por: Lang, David
Publicado: (2013)

Health research knowledge translation into policy in Zambia: policy-maker and researcher perspectives
por: Malama, Annie, et al.
Publicado: (2021)

The challenge of bridging the gap between researchers and policy makers: experiences of a Health Policy Research Group in engaging policy makers to support evidence informed policy making in Nigeria
por: Uzochukwu, Benjamin, et al.
Publicado: (2016)

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
por: Greenberg, Paul E., et al.
Publicado: (2021)

Summary Quality Scores for Pharmacoeconomic Studies: Balancing Validity With Need
por: Shaya, Fadia T., et al.
Publicado: (2003)

Resistance Economy and New Population Policy in Iran
por: Poorolajal, Jalal
Publicado: (2017)

The importance of publishing research protocols for pharmacoeconomic studies
por: Dane, Aniek, et al.
Publicado: (2023)

Reflections from Key Policy Decision-makers on Integrated Care and the Value of Decision-maker Involvement in Research
por: Evison, Karen, et al.
Publicado: (2018)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

Increasing the use of evidence in health policy: practice and views of policy makers and researchers
por: Campbell, Danielle M, et al.
Publicado: (2009)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Appropriateness for Total Joint Replacement: Perspectives of Decision-Makers
por: Clavel, Nathalie, et al.
Publicado: (2016)

Regulating international clinical research: an ethical framework for policy-makers
por: Aguilera, Bernardo, et al.
Publicado: (2020)

A tool for communication with decision-makers: limitations and utilization of studies on cost of illness
por: Lee, Kun-Sei
Publicado: (2011)

Getting Research to the Policy Table: A Qualitative Study With Public Health Researchers on Engaging With Policy Makers
por: Otten, Jennifer J., et al.
Publicado: (2015)

Quality of pharmacoeconomic research in China: A systematic review
por: Ma, Huifen, et al.
Publicado: (2016)

Accuracy in Pharmacoeconomic Literature Review: Lessons Learned From the Navajo Code Talkers
por: Fairman, Kathleen A.
Publicado: (2008)

Pharmacoeconomics - Determiniation of the Cost-Effectiveness of Helicobacter Pylori Eradication
por: Curtiss, Frederic R.
Publicado: (2003)

Mutual Distrust: Perspectives From Researchers and Policy Makers on the Research to Policy Gap in 2013 and Recommendations for the Future
por: Gollust, Sarah E., et al.
Publicado: (2017)

Intervention Scalability Assessment Tool: A decision support tool for health policy makers and implementers
por: Milat, Andrew, et al.
Publicado: (2020)

Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community
por: Miri, Seyed Mohammad, et al.
Publicado: (2011)

Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers
por: Chirico, Francesco, et al.
Publicado: (2021)

Climate research priorities for policy-makers, practitioners, and scientists in Georgia, USA
por: Rudd, Murray A., et al.
Publicado: (2018)

How is the use of research evidence in health policy perceived? A comparison between the reporting of researchers and policy-makers
por: Ellen, Moriah E., et al.
Publicado: (2018)

Health systems and policy research evidence in health policy making in Israel: what are researchers’ practices in transferring knowledge to policy makers?
por: Ellen, Moriah E, et al.
Publicado: (2014)

The how and why of producing policy relevant research: perspectives of Australian childhood obesity prevention researchers and policy makers
por: Newson, Robyn, et al.
Publicado: (2021)

Serial Deaths of Young Trainee Physicians in Iran During COVID-19 Pandemic; Messages to Policy Makers
por: Gharebaghi, Reza, et al.
Publicado: (2022)

Who decided the new energy vehicles policy in China? From the perspective of policy objects and policy makers
por: Xu, Wenwen, et al.
Publicado: (2023)

What Is Physical Activity? A Holistic Definition for Teachers, Researchers and Policy Makers
por: Piggin, Joe
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ih55b5p31sga4pdfbm27hq7vft